Literature DB >> 2598989

The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage.

L F Prescott1, J W Donovan, D R Jarvie, A T Proudfoot.   

Abstract

Seventeen patients received standard treatment with intravenous N-acetylcysteine for 18 episodes of severe poisoning with paracetamol (acetaminophen). The dose of N-acetylcysteine was 150 mg/kg given in 15 min followed by 50 mg/kg in 4 h and 100 mg/kg over the next 16 h. Liver damage was absent or mild on 13 occasions (ALT greater than 500 mu/l) and severe on 5 (ALT less than 1000 mu/l). Total plasma N-acetylcysteine was estimated by HPLC. The mean maximum plasma concentration after the initial loading dose was 554 mg/l. Concentrations then fell rapidly and after 12 h a mean steady-state level of about 35 mg/l was maintained. When the infusion was discontinued N-acetylcysteine disappeared with a half-life of 5.7 h. The mean steady-state volume of distribution, AUC, mean residence time and total clearance were 536 ml/kg, 1748 mg.h.l-1, 2.91 h and 3.18 ml.min-1.kg-1. These values are generally consistent with those previously reported with much smaller doses and the disposition of N-acetylcysteine does not appear to be dose-dependent. The elimination of N-acetylcysteine was not impaired in the patients with severe liver damage, and the pharmacokinetic variables and plasma concentrations were similar in patients with and without hepatotoxicity. The dosage schedule for intravenous N-acetylcysteine should probably be modified since adverse reactions invariably occur early when plasma concentrations are at their highest, and liver damage was prevented just as effectively at the lowest as at the highest Cmax. High initial concentrations of N-acetylcysteine can be avoided with simple alternative regimens based on the kinetic data of this study.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2598989     DOI: 10.1007/bf00558131

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration.

Authors:  J M Burgunder; A Varriale; B H Lauterburg
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  The role of acetylcysteine in clinical toxicology.

Authors:  R J Flanagan
Journal:  Med Toxicol       Date:  1987 Mar-Apr

3.  Asthma associated with N-acetylcysteine infusion and paracetamol poisoning: report of two cases.

Authors:  S W Ho; L J Beilin
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

4.  High performance liquid chromatographic estimation of paracetamol metabolites in plasma.

Authors:  P I Adriaenssens; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

5.  High-performance liquid chromatographic determination of N-acetylcysteine in human serum following acetaminophen overdosage.

Authors:  M R Holdiness; L R Morgan; L E Gillen; E F Harrison
Journal:  J Chromatogr       Date:  1986-10-31

6.  Adverse reactions to acetylcysteine and effects of overdose.

Authors:  T G Mant; J H Tempowski; G N Volans; J C Talbot
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-28

7.  Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers.

Authors:  L De Caro; A Ghizzi; R Costa; A Longo; G P Ventresca; E Lodola
Journal:  Arzneimittelforschung       Date:  1989-03

8.  Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo.

Authors:  B H Lauterburg; G B Corcoran; J R Mitchell
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

9.  Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine.

Authors:  L F Prescott; J Park; A Ballantyne; P Adriaenssens; A T Proudfoot
Journal:  Lancet       Date:  1977-08-27       Impact factor: 79.321

10.  Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.

Authors:  J D Horowitz; C A Henry; M L Syrjanen; W J Louis; R D Fish; T W Smith; E M Antman
Journal:  Circulation       Date:  1988-04       Impact factor: 29.690

View more
  43 in total

Review 1.  [Good sense and nonsense of antitussive agents].

Authors:  A Gillissen; S Tasci; S Ewig; H Schäfer; S Zielen
Journal:  Internist (Berl)       Date:  2001-01       Impact factor: 0.743

2.  Pharmacokinetics of intravenous N-acetylcysteine in men at rest and during exercise.

Authors:  Malcolm Brown; Andrew Bjorksten; Ivan Medved; Michael McKenna
Journal:  Eur J Clin Pharmacol       Date:  2004-11-20       Impact factor: 2.953

3.  EJCP and clinical toxicology: the first 40 years.

Authors:  D N Bateman
Journal:  Eur J Clin Pharmacol       Date:  2007-11-16       Impact factor: 2.953

Review 4.  Combined butalbital/acetaminophen/caffeine overdose: case files of the Robert Wood Johnson Medical School Toxicology Service.

Authors:  Christopher Bryczkowski; Ann-Jeannette Geib
Journal:  J Med Toxicol       Date:  2012-12

5.  N-acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid.

Authors:  W A De Backer; B Amsel; P G Jorens; L Bossaert; P S Hiemstra; P van Noort; F J van Overveld
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

6.  Antenatal pharmacokinetics and placental transfer of N-acetylcysteine in chorioamnionitis for fetal neuroprotection.

Authors:  Donald B Wiest; Eugene Chang; Deanna Fanning; Sandra Garner; Toby Cox; Dorothea D Jenkins
Journal:  J Pediatr       Date:  2014-07-23       Impact factor: 4.406

7.  N-acetylcysteine manipulation fails to elicit an increase in glutathione in a teleost model.

Authors:  Kim Birnie-Gauvin; Martin H Larsen; Kim Aarestrup; William G Willmore; Steven J Cooke
Journal:  Fish Physiol Biochem       Date:  2017-08-31       Impact factor: 2.794

Review 8.  Evidence for the changing regimens of acetylcysteine.

Authors:  Angela L Chiew; Geoffrey K Isbister; Stephen B Duffull; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2015-11-23       Impact factor: 4.335

9.  Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects.

Authors:  T T Knudsen; S Thorsen; S A Jensen; K Dalhoff; L E Schmidt; U Becker; F Bendtsen
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 10.  Role of N-acetylcysteine in the management of COPD.

Authors:  Anna M Sadowska; J Verbraecken; K Darquennes; W A De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.